Latest news with #TesticularCancerAwarenessMonth
Yahoo
23-04-2025
- Health
- Yahoo
West Dunbartonshire Council to support National Testicular Cancer Awareness month
West Dunbartonshire Council could team up with a local charity to see how they can help support National Testicular Awareness month. April is designated as Testicular Cancer Awareness Month in the UK to raise awareness about this cancer, which is highly treatable when caught early. It affects mostly men between the age of 15 and 45 and is one of the most curable if detected early. READ MORE: Jet2, Ryanair, Easyjet, TUI passengers told to stop flying in certain footwear READ MORE: Police close multiple Glasgow roads 'near train station' in ongoing incident Cahonas Scotland, situated in Clydebank at the Titan Enterprise Centre, provides advice and education on the disease as well as the benefits of regular self checks. They state on their website that the highest incidence rates are among men aged 30—34 but cases have increased by more than 27% since the early 1990s. Statistics also show that 2400 men are diagnosed in the UK each year which is more than six men per day but survival rates have also risen every year since the 1970s. Cahonas Scotland believes that early detection means more effective treatment. Regular checks are important for every man you know and every man needs to know what to look for. The charity carried out its work at schools, colleges, community hubs and events and wants to get everyone talking — and checking. A motion on testicular cancer awareness is being presented at West Dunbartonshire's full council meeting this Thursday by councillor Clare Steel. Councillor Steel's motion reads: '[This] council notes that Cahonas Scotland is a charity that helps to raise awareness of the signs and symptoms of Testicular Cancer. 'Research suggests that this is the most common cancer in men but it is not talked about enough. Locally, there is a small but dedicated team of two who can provide help and support to those affected. 'Council also notes that the month of April will be Testicular Cancer Awareness Month. This Council thanks Cahonas Scotland for all the work that they do and agrees to look at how we could support National Testicular Cancer Awareness month.' Join Glasgow Live's WhatsApp community here and get the latest news sent straight to your messages
Campaign ME
15-04-2025
- Sport
- Campaign ME
FP7 McCann combats cancer in ‘ballsy' campaign during CD Leganés vs. Barcelona FC game
During a sold-out La Liga showdown against FC Barcelona, CD Leganés made history — not for goals scored, but for where they placed the the Testicular Cancer Society's logo — as part of its Sponsored Balls campaign brought to life by FP7 McCann. In a cheeky and powerful move, the club unveiled a testicular-region sponsorship, with the logo directly on players' shorts — in the exact region the disease affects. The Sponsored Balls campaign was created by FP7McCann to mark Testicular Cancer Awareness Month and spark a conversation that millions of men often avoid. Federico Fanti, Regional Chief Creative Officer, FP7McCann MENAT, said, 'In football, every inch of the kit is branded, from sleeves to socks, but no one's ever dared to sponsor the area that actually matters for this conversation. So, we found the ultimate white space in sponsorship, one that perfectly aligned message and medium. Its power lies in simplicity of the idea: put the message where men need to look — on themselves, while watching the thing they love most: the beautiful game.' Rollout of the cancer awareness campaign: From billboards to broadcasts Sponsored Balls flips the script, placing attention not on the sponsor itself, but on the cause — men's health. In a sport saturated with logos, this previously untouched zone became the most meaningful, The Testicular Cancer Society's logo, a simple cherry-like design in purple color was placed at the center of the players' shorts. Subtle in execution but bold in implication, the placement turned an often-ignored space into a direct and powerful reminder: check yourself. Accompanying the visual was the rallying cry #TenemosUnPar ('We have a pair') — a message broadcast across stadium signage, digital billboards, and live broadcasts, encouraging men to take the conversation online, share stories, and more importantly, check themselves. CD Leganés captain Sergio González, who led the team in the now-iconic shorts, said, 'Football gives us a platform few others have. Some teammates didn't even know how to check themselves before this. Now they do. If showing our pair helps save even one life — that's a win beyond football.' Testicular cancer is the most common cancer in young men — yet remains one of the least talked about. Despite 1 in 250 men being diagnosed, awareness and regular self-exams are dangerously low. That's the insight that sparked this campaign: if men aren't looking down there on their own, maybe football can give them a reason to. Michael Craycraft, founder of the Testicular Cancer Society, called the stunt 'the most effective few seconds in testicular cancer awareness history,' adding: 'We've spent years trying to normalise self-exams through traditional means, reaching thousands. This campaign reached millions in one shot — getting people talking like never before.' Impact of the Sponsored Balls campaign The campaign witnessed an immediate, measurable impact with #TenemosUnPar trending within within minutes of kickoff. More than two million unique visitors reportedly landed on the Testicular Cancer Society website, which is more than what the website has witnessed in the past three years combined. 'Sponsored Balls' builds on last year's award-winning 'Highlight Your Balls' initiative, which turned wall setups in free-kick highlights into self-check tutorials. Craycraft closed with a global challenge: 'This campaign changed how we reach men who need this message most. With CD Leganés leading the way, we're calling on clubs around the world to dedicate just one match to this cause. The impact could be lifesaving.' CREDITS: Client: Testicular Cancer Society and CD Leganés Football Club Founder Mike Craycraft Testicular Cancer Society Director of Communications & Marketing Víctor Marín CD Leganés Football Club Digital & Audiovisual Content Manager Jaime del Campo CD Leganés Football Club Chief of Protocol Nerea Cacho CD Leganés Football Club Marketing Coordinator Adrian Lozano CD Leganés Football Club Creative agency: FP7 McCann Regional Chief Creative Officer Federico Fanti FP7 McCann Dubai Executive Creative Director Nayaab Rais FP7 McCann Dubai Senior Creative Director & Head of Art Paulo Engler FP7 McCann Dubai Creative Director Art Jonathan Cruz FP7 McCann Dubai Associate Creative Director Art Bruno Montoro FP7 McCann Dubai Associate Creative Director Copy Rob Hall FP7 McCann Dubai Senior Copywriter Diego Fernandez-Cid FP7 McCann Dubai Senior Art Director Arthur Melo FP7 McCann Dubai PR Manager Roksar Kamal FP7 McCann Dubai Creative Excellence: McCann WorldGroup Global CCO Javier Campopiano McCann Worldgroup Global ECD & CCO Europe, Adrian Botan McCann Worldgroup Global Product Excellence Director Carmem Bistrian McCann Worldgroup Creative Excellence Senior Manager Lara De Souza MCN Creative Excellence Manager Sofia Serrano FP7 McCann Dubai Production: FP7 McCann Dubai Motion Designer Kaue Akimoto FP7 McCann Dubai Video Editor Murilo DePaula FP7 McCann Dubai Director Yago Casariego Freelancer CS: Managing Director Tarek Ali Ahmad FP7 McCann Dubai PR: Chief Communications Officer Lizzie Dewhurst MCN Managing Director Peter Jacob Current Global Client Director Charlotte Joseph Marketiers
Yahoo
11-04-2025
- Health
- Yahoo
Medical Boost for Young Men as New, Highly Accurate Early Detection Testicular Cancer Test Launched by EDX Medical in UK
CAMBRIDGE, England, April 11, 2025--(BUSINESS WIRE)--The world's most advanced early detection test for testicular cancer – now the most common form of cancer among young men – is being launched in the UK. The non-invasive test has exceptional sensitivity in a broad range of men across ethnicities and ages and also detects cancer recurrences at ultra-high accuracy with 100% sensitivity following treatment and during ongoing surveillance of testicular cancer survivors. There are around 2,500 new cases of testicular cancer in the UK every year and 50,000 survivors of testicular cancer who could benefit from accurate post-treatment monitoring. Notable survivors in the UK who campaign for greater awareness of the disease include actor Jack James Ryan, formerly of Coronation Street, radio presenter Chris Stark and former Welsh international footballer, John Hartson. The test is being launched in the UK by EDX Medical, a Cambridge-based company which specialises in developing and supplying digitally enhanced diagnostic tools for cancer, cardiovascular and infectious diseases. April is Testicular Cancer Awareness Month, and many cancer charities and patient advocacy groups aim to highlight the benefits of early detection. Survival rates for testicular cancer are in excess of 90% if the disease is identified and treated early. The EDX Medical test ("TC100") involves the taking of a simple blood sample which is sent to EDX Medical for laboratory analysis. The blood sample can be taken easily by a health professional. Multiple specific tumour biomarkers are analysed and, using a proprietary AI-powered algorithm, a detailed report is prepared for clinicians to help determine the presence or absence of disease and to help guide treatment if required. Over 30 clinical study reports have confirmed the accuracy and potential clinical usefulness of the test biomarkers, encompassing its use in primary diagnosis, early detection, metastatic disease and recurrence of both seminoma and non-seminoma testicular cancer. Combining proprietary M371 micro-RNA biomarker analysis with the classic three serum biomarkers AFP - Alpha-fetoprotein, HCG - Human Chorionic Gonadotrophin and LDH - Lactate Dehydrogenase, using a unique algorithm, the new "TC100" assay provides exceptional accuracy and sets a new standard for testicular cancer testing. The TC100 test reports on the three tumour biomarkers currently included in the NHS testicular cancer treatment pathway as part of the analysis and for ease of reference. The test provides up to 99% sensitivity and 96% specificity in primary diagnosis and 100% in monitoring recurrence. The test, which is to be used by health professionals as an aid to their clinical diagnosis, will be available to all private sector and public healthcare providers within several weeks. Professor Sir Chris Evans, OBE, founder of EDX Medical Group plc, commented: "Testicular cancer is a nightmarish thought for young men and there has been a lack of awareness over what to do and an unwillingness to get tested. "We are delighted to launch in the UK now the best test ever made. Given that this disease affects boys from 15 years old to men in their early forties, there are many who could benefit from testing in terms of reassurance and this particularly applies to people who have been diagnosed and need checked on a regular basis." Jack James Ryan, who campaigns on behalf of the Teenage Cancer Trust, commented: "There's still such a huge stigma around testicular cancer especially with the process of getting physically checked in the private parts and that needs to change. Even after your initial check you need to be scanned if there are concerns, so you still don't know the outcome of what you have been worried about. "Being able to give a simple blood sample that is then analysed and that tells you with a high degree of certainty whether you have this cancer or not - as opposed to the physical examinations - would eliminate the awkward and uncomfortable physical process that so many young men shy away from. By making the process of detection easier and more casual - and very accurate - it'll convince more young men to get tested quicker and in turn will save lives. This really is a game changer!" Dr Karen Robb, Director of Programme Implementation for Cancer at Movember, the leading men's health charity, commented: "This test is a great step and a part of the bigger picture to improve early diagnosis. During Testicular Cancer Awareness Month, Movember is reminding young men to 'Know Thy Nuts' — that means getting familiar with what's normal for your body and speaking up if something doesn't feel right. Early detection starts with awareness, and knowing your risks can save your life." Leading Michelin-starred chef and restaurateur, Andreas Antona, was diagnosed with testicular cancer in 2012 and believes early testing will be life-saving for young men. He said: "We all say that if we knew then what we know now, we'd have made different decisions and how true that is when it comes to cancer. Early detection will undoubtedly save young men's lives and prevent much unnecessary suffering by earlier intervention. This type of testing can also give great peace of mind and help someone live life without worrying about cancer all the time." Dr Mike Hudson, CEO, EDX Medical, said: "The highly sensitive "TC100" testicular cancer test will help doctors to accurately identify testicular cancer early and better manage the safe and effective care of their patients. The quick confirmation of early signs of disease, the absence of cancer following treatment and to monitor any signs of recurrence during surveillance will help minimise scans, biopsies and the unnecessary use of toxic chemotherapy, significantly improving quality of life for patients." Notes for Editors: About EDX Medical Group EDX Medical Group plc is listed on the Apex Segment of the AQSE Growth Market (TIDM: EDX). EDX Medical was founded by Professor Sir Christopher Evans, OBE, a medical and life sciences entrepreneur with more than 30 years of experience, together with CEO, Dr Mike Hudson. By translating clinical insights into pragmatic solutions combining advanced biological and digital technologies, EDX Medical seeks to cost effectively improve the detection and characterisation of disease in order to personalise treatment in a timely fashion. Early disease detection and biologically-based personal treatment optimisation is considered to be the most impactful way of reducing deaths and lowering the cost of healthcare globally. EDX Medical Group provides doctors, hospitals and insurers/payers with access to a portfolio of the best clinical diagnostics products and services. The Company operates its own facilities in Cambridge and Oxford, UK, and has strategic product and technology partnerships with organisations such as Thermo Fisher EMEA Ltd, a world leader in supplying life sciences solutions and services. EDX Medical conducts product development, validation and distribution to ISO 13485 and provides PCR and genomic sequencing services accredited to ISO 15189 by the United Kingdom Accreditation Service (UKAS). View source version on Contacts Media contacts: Media House International Ramsay Smith +44 (0)7788 414856 ramsay@ Gary McQueen + 44 (0)7834 694609 gary@ Sign in to access your portfolio
Euronews
09-04-2025
- Health
- Euronews
Testicular cancer: What are the signs to look out for and how do you check you have it?
ADVERTISEMENT Testicular cancer may be rare, but it's the most common form of cancer facing young men. It's also one of the most treatable cancers if it's caught early. Survival rates are high, with 95 per cent of men under age 45 surviving at least five years after diagnosis, European data shows. But because there are few symptoms, men may not realise they have testicular cancer, leading to delays in diagnosis that can make treatment more complicated. Part of the problem is that 'there is no self-examination culture' due to social 'taboos,' said Dr Hendrik Van Poppel, a urologist on the board of the European Association of Urology (EAU) and co-chair of the inequalities network hosted by the European Cancer Organisation. Related 'Who knew a pair of undies could hold so much power': New underwear labels to raise cancer awareness With Testicular Cancer Awareness Month in full swing, here's what you need to know to take charge of your health. Who is at risk of testicular cancer? Testicular cancer affects about one in every 250 men in Europe, and it's the most common cancer among those under age 45 . Diagnoses peak in the late 20s and early 30s. Some men are at higher risk of testicular cancer, including those with a family history of it, men with HIV or fertility problems, white men, and those with cryptorchidism. Cryptorchidism is a condition where the testicles do not descend into the scrotum, which they normally do around the time a baby boy is born. About 5 to 10 per cent of men with testicular cancer had the condition, which can be fixed with surgery, as a child. What are the signs of testicular cancer? Van Poppel told Euronews Health that young men and teenage boys should do self-examinations while in a warm shower or bath, when the scrotum is relaxed. Check each testicle separately for lumps or changes. Related World Cancer Day: Forever chemicals in tap water might cause cancer to spread, study finds According to the EAU , most changes you might find during a self-exam are not cancer. But if you find a small, painless lump in the testicle it could be serious, so follow up with a doctor. Other warning signs include a testicle getting bigger or painful, or the scrotum feeling firm, hard, heavy, or achy, the UK National Health Service (NHS) said. Pain in your back or lower stomach, losing weight, having a cough or a hard time breathing or swallowing, and a sore chest can all be symptoms as well. What is life like after a testicular cancer diagnosis? Treatment typically involves surgery to remove the testicle, sometimes followed by chemotherapy or radiation. Some people opt to get an artificial testicle put in to replace the one they lost in surgery, according to the NHS. Related Men with higher quality sperm may have longer lifespan, new study finds Some testicular cancer treatments can affect fertility, meaning it could be harder to have children. Before beginning treatment, you may want to consider storing and banking your sperm, which could be used for fertility treatments in the future. If the cancer has spread to other parts of the body, it can be harder to treat. In that case, doctors may offer more intensive treatments or palliative care to manage your symptoms as long as possible. ADVERTISEMENT The bottom line, Van Poppel said, is that testicular cancer doesn't have to be a death sentence. 'Many of these guys who are discovered late, even metastatic, can be cured,' Van Poppel said. 'But the main goal should be timely detection'.
Yahoo
07-04-2025
- Health
- Yahoo
Don't Drop the Ball: Movember Urges Men to ‘Know Thy Nuts' This Testicular Cancer Awareness Month
TORONTO, April 02, 2025 (GLOBE NEWSWIRE) -- Testicular Cancer Awareness Month is here, and Movember – the world's leading men's health charity – is asking men to get hands-on with their health during its annual 'Know Thy Nuts' campaign. The ballsy initiative is an important reminder that testicular cancer remains the number one cancer among young men. It also highlights the importance, ease, and benefits of regularly checking in on the family jewels. Despite its prevalence, too many Canadian young men remain in the dark about testicular cancer, with 74% of young men claiming not to know their age group is at risk. A 2024 Movember survey found that: Most Canadian young men (75%) do not know that testicular cancer is the most common cancer in young men aged 15-40. Only 22 per cent of Canadian young men feel very confident they'd be able to check their nuts/testicles for irregularities and shockingly, 1 in 4 Canadian young men shared they've never checked their pair. While 70 per cent of Canadian young men say they would make a doctor's appointment if they noticed something abnormal with their nuts/testicles, only 24 per cent say they would share it with their partner and even less (18%) would share it with a family member they trust. Nearly 1 in 4 (23%) of Canadian young men would not visit a doctor unless their nuts/testicles were in extreme pain, with a staggering 35% saying they wouldn't be due to embarrassment. The reality? Since 2020, approximately 75,000 new testicular cancer cases have been reported worldwide each year, with more than 11,000 men dying from the disease annually. Yet, when caught early, the disease is highly treatable. It's Time to Get Hands-On with Your Health The good news? Checking yourself is quick and easy. Movember's cheeky 'Know Thy Nuts' Guide shows men exactly how to check their pair, what's normal, and what to do if something feels off."Testicular Cancer Awareness Month is about taking control of your health. The simplest action that young men can take is to get to know their nuts. That way, if they notice any changes over time, they can get it checked by a doctor. When caught early, testicular cancer is highly treatable," said Professor Simon Rice, Global Director of the Movember Institute of Men's Health. The Movember survey found that 84% of men who visited its 'Know Thy Nuts' site felt confident in knowing how to perform self-checks afterwards – a simple step that could save lives. Raising Awareness, Funding Research, and Changing Outcomes Since 2008, Movember has invested nearly AUD $640 into biomedical research projects focused on prostate cancer and testicular cancer. As one of the largest NGOs investing in testicular cancer research and programs, Movember has funded over 25 testicular cancer projects worldwide. By working alongside leading cancer researchers and men with lived experience, Movember is driving progress to improve detection, treatment, and outcomes for those diagnosed. This April, don't drop the ball. Take a few minutes to check your pair, learn what's normal for you, and encourage other guys to do the same. Visit and help spread the word. For those navigating a testicular cancer diagnosis, Movember's Nuts & Bolts hub – co-designed with survivors – offers support, advice, and community. Survey MethodologyThis study was fielded by Dynata who surveyed a total of 4,000 young males aged as young as 16 years old and up to 40 years across 4 different markets – Australia, Canada, UK and the USA – from 23rd February 2024, through to 4th March 2024. The survey results were collected based upon 1,000 Nat Rep Males, across each market. About Movember:Twenty-two years ago, a bristly idea was born in Australia, igniting a movement that would transcend borders and change the face of men's health forever. The movement, known as Movember, united people from all walks of life, sparking important conversations, raising vital funds, and shattering the silence surrounding men's health issues. Since 2003, Movember has challenged the status quo, shaken up men's health research, and transformed the way health services reach and support men – taking on prostate cancer, testicular cancer, mental health, and suicide prevention with unwavering determination. Movember has raised over AUD 1.7 billion for men's health, thanks to their passionate community. These critical funds have delivered more than 1,300 men's health projects around the world, funding some of the largest prostate cancer registries based on the real-life experiences of hundreds of thousands of men. Since taking on mental health and suicide prevention in 2006, Movember has emphasised the importance of better social connections, early recognition of poor mental health, and how clinicians can better respond to men in distress. They want to ensure that more men know what to do when mental health issues appear and that their supporters are better prepared to step in when needed. Movember will continue championing new research, cutting-edge treatments, and healthy behaviours. They will also continue advocating for inclusive, gender-responsive healthcare systems that are tailored to the unique needs of men, women, and gender-diverse people from a range of cultural backgrounds. In doing so, they hope to forge a future where barriers to healthy living are overcome, stigmas are removed, and everyone has an equal opportunity to live a long, healthy life. By improving men's health, Movember aims to have a profoundly positive impact on women, families, and society. To learn more, please visit A photo accompanying this announcement is available at CONTACT: For media requests and interview opportunities with a testicular cancer survivor and/or Movember subject matter experts, please contact: Taffin Sekulin, PR Manager of Canada in to access your portfolio
